Glucose intolerance in cystic fibrosis patients

Paediatric Respiratory Reviews

Volumn 2, Issue 3, 2001, Pages 253-259

  Lanng, S ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cystic fibrosis; Cystic fibrosis related diabetes; Diabetes mellitus; Glycated haemoglobin A1c; Late diabetic complications; Mortality; Oral glucose tolerance test

Indexed keywords

AMYLOID PROTEIN; BIGUANIDE DERIVATIVE; C PEPTIDE; GASTROINTESTINAL HORMONE; GLUCAGON; GLUCOCORTICOID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; ISOPHANE INSULIN; MESSENGER RNA; ORAL ANTIDIABETIC AGENT; PANCREAS POLYPEPTIDE; SULFONYLUREA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CYSTIC FIBROSIS; DIABETES MELLITUS; EARLY DIAGNOSIS; ENDOCRINE DISEASE; GENE MUTATION; GENETIC DISORDER; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GROUPS BY AGE; HEALTH STATUS; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TREATMENT; LONGEVITY; MICROANGIOPATHY; MORBIDITY; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0035736724     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1053/prrv.2001.0148     Document Type: Article

References (41)

1. European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations
2. Diabetes mellitus in Danish cystic fibrosis patients: Prevalence and late diabetic complications
3. Abnormal glucose metabolism in cystic fibrosis
4. Diabetes mellitus in cystic fibrosis: A ten-year prospective study
5. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus
6. Diabetes mellitus
7. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
8. Diagnosis of cystic fibrosis related diabetes: A selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria
9. Diabetes mellitus associated with cystic fibrosis
10. Glucose tolerance in patients with cystic fibrosis: A five-year prospective study
11. Cystic fibrosis-related diabetes: An approach to diagnosis and management
12. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis
13. Glucose tolerance in cystic fibrosis
14. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator
15. Localization of the cystic fibrosis transmembrane conductance regulator in pancreas
16. Cystic fibrosis associated islets changes may provide a basis for diabetes
17. Pancreatic endocrine function in cystic fibrosis
18. The relationship between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta-F508)
19. Diabetes mellitus in cystic fibrosis: Genetic and immunological markers
20. Cystic fibrosis-related diabetes is associated with HLA DQBI alleles encoding Asp-57 sup(-) molecules
21. Role of autoimmunity in insulinopenic and carbohydrate derangements in patients with cystic fibrosis
22. Hormonal abnormalities of the pancreas and gut in cystic fibrosis
23. Adult cystic fibrosis: Postprandial response of gut regulatory peptides
24. Pancreatic polypeptide in cystic fibrosis
25. Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis
26. Pancreas and gut hormone reponses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance
27. Preservation of somatostatin secretion in cystic fibrosis patients with diabetes
28. Insulin responses to intravenous glucose and the hyperglycemic clamp in cystic fibrosis patients with different degrees of glucose tolerance
29. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance
30. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance
31. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis
32. Insulin sensitivity in cystic fibrosis
33. Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis
34. Insulin resistance is associated with decreased clinical status in cystic fibrosis
35. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis
36. Diabetes mellitus in cystic fibrosis: Effect of insulin therapy on lung function and infections
37. Trends in pulmonary function in patients with cystic fibrosis correlates with the degree of glucose intolerance at baseline
38. Glucose intolerance in cystic fibrosis
39. Effect of tolbutamide on growth and body composition of non-diabetic children with cystic fibrosis
40. Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance